Physician

Shahid Hussain, M.D.

According to 2025 Medicare claims, Shahid Hussain, M.D. (NPI: 1063497220) practices nephrology in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is BALBOA NEPHROLOGY MEDICAL GROUP, INC. (NPI: 1316997505; TIN: 952848091) and primary practice location at 92243-9632.

Hussain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 688 traditional Medicare patients, billed 6,478 HCPCS/CPT codes, and received $528,799 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,171 prescription claims across 369 beneficiaries totaling $827,080 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 261 claims. Open Payments data shows 7 records totaling $363. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,505 and ending at $1,833.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	966	18,360	$510,849
2016	943	7,539	$491,468
2017	935	6,801	$493,594
2018	833	5,998	$455,972
2019	821	5,831	$465,143
2020	833	4,044	$459,670
2021	747	3,588	$551,838
2022	584	3,207	$445,473
2023	584	3,097	$451,022
2024	688	6,478	$528,799

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	428	4,764	$626,958
2016	456	5,376	$1,097,379
2017	540	6,493	$1,257,086
2018	515	5,170	$1,073,096
2019	472	4,429	$1,394,987
2020	456	4,586	$1,483,585
2021	473	4,585	$1,721,188
2022	410	3,832	$1,717,733
2023	348	3,086	$1,463,891
2024	369	3,171	$827,080

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	47	677	$56,276
2016	69	782	$53,804
2017	63	760	$35,169
2018	60	636	$32,651
2019	61	578	$29,482
2020	55	461	$20,285
2021	37	557	$21,634
2022	N/R	334	$16,892
2023	N/R	250	$7,852
2024	N/R	261	$4,987

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	501	$55
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	250	916	$42
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	226	1,220	$33
99453	Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment	169	169	$17
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	171	339	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	34	1,740	$165,694
Farxiga	Dapagliflozin Propanediol	129	4,950	$88,316
Jardiance	Empagliflozin	133	4,290	$80,588
Veltassa	Patiromer Calcium Sorbitex	64	2,587	$65,583
Kerendia	Finerenone	82	2,760	$58,132

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	61	$1,292
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	60	$1,107
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	25	$1,020
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	56	$979
J7500	Azathioprine, oral, 50 mg	N	N/R	13	$564

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$363	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shahid Hussain, M.D.?

Tedicare shows public-source Medicare data for Shahid Hussain, M.D. (NPI 1063497220), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shahid Hussain, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shahid Hussain, M.D.?

Shahid Hussain, M.D. is linked to BALBOA NEPHROLOGY MEDICAL GROUP, INC. (billing NPI 1316997505) in the available physician profile data.

Does Shahid Hussain, M.D. have Open Payments data?

Shahid Hussain, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.